Debridement and wound bed preparation

Dermatologic Therapy

Volumn 19, Issue 6, 2006, Pages 317-325

  Falabella, Anna F ^a,b  

^a Dermatology and Cosmetic Specialists   (United States)

^b NONE   (United States)

Author keywords

Debridement; Humans; Wound healing

Indexed keywords

ACCUZYME; ACETIC ACID; ANTIINFECTIVE AGENT; CADEXOMER IODINE; CHLOROPHYLL; CHLOROPHYLL COPPER COMPLEX; COLLAGENASE; COPPER COMPLEX; DEOXYRIBONUCLEASE; DEXTRANOMER; ELASE; ETHEZYME; FIBRINOLYSIN PLUS DEOXYRIBONUCLEASE; GLADASE; GRANULEX; HYDROGEN PEROXIDE; HYPOCHLORITE SODIUM; IODOFLEX; KOVIA; PANAFIL; PANAFIL WHITE; PAPAIN; PAPAIN PLUS UREA PLUS CHLOROPHYLLIN COPPER COMPLEX; PLACEBO; PLASMIN; POVIDONE IODINE; STREPTODORNASE PLUS STREPTOKINASE; TRYPSIN; UREA; XENADERM; ZIOX;

AUTOLYTIC DEBRIDEMENT; CHEMICAL DEBRIDEMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPRESSION THERAPY; DEBRIDEMENT; DECUBITUS; DIABETIC FOOT; FOOT ULCER; HUMAN; HYDROTHERAPY; INTERMETHOD COMPARISON; LEG ULCER; MAGGOT THERAPY; MECHANICAL DEBRIDEMENT; MOISTURE; MONOTHERAPY; NONHUMAN; PATIENT SAFETY; PRESSURE; REVIEW; SURGICAL DEBRIDEMENT; TREATMENT OUTCOME; WOUND; WOUND CARE; WOUND DRESSING; WOUND INFECTION; WOUND IRRIGATION;

DEBRIDEMENT; HUMANS; SKIN CARE; WOUND HEALING; WOUNDS AND INJURIES;

EID: 33845640023     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2006.00090.x     Document Type: Review

References (55)

1. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: systematic approach to wound management. Wound Repair Regen 2003: 11: 1-28.
2. Sibbald RG, Orsted H, Schultz GS, et al. Preparing the wound bed 2003: focus on infection and inflammation. Ostomy Wound Manage 2003: 49: 24-51.
3. Lyons AS, Petrucelli RJ. Medicine: an illustrated history. New York: Henry A. Abrams Publications, 1987.
4. Hellgren L, Vincent J. Debridement: an essential step in wound healing. In: Westerhof W, ed. Leg ulcers: diagnosis and treatment. Amsterdam: Elsevier Science Publishers, 1993: 305-312.
5. Ovington LG. The well-dressed wound: an overview of dressing types. Wounds 1998: 10 (Suppl. A): 1A-11A.
6. Kerstein M. Moist wound healing: the clinical perspective. Ostomy Wound Manage 1995: 41: 37S-44S.
7. Levine N, Seifter E, Connerton C, et al. Debridement of experimental skin burns of pigs with bromelain, a pineapple stem enzyme. Plast Reconstruct Surg 1973: 52: 413-424.
8. Donati L, Magliano E, Colonna M, et al. Surgical versus enzymatic debridement. In: Westerhof W, Vanscheidt W, eds. Proteolytic enzymes and wound healing. New York: Springer-Verlag, 1994: 38-39.
9. Berger MM. Enzyme debriding preparations. Ostomy Wound Manage 1993: 39: 61-62, 66-69.
10. Wollina U, Liebold K, Schmidt WD, et al. Biosurgery supports granulation and debridement in chronic wounds - clinical data and remittance spectroscopy measurement. Int J Dermatol 2002: 41: 635-639.
11. Sherman RA. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care 2003: 26: 446-451.
12. Mumcuoglu KY, Ingber A, Gilead L, et al. Maggot therapy for the treatment of intractable wounds. Int J Dermatol 1999: 38: 623-627.
13. Sherman RA, Wyle F, Vulpe M. Maggot therapy for treating pressure ulcers in spinal cord injury patients. J Spinal Cord Med 1995: 18: 71-74.
14. Eaglstein WH. Moist wound healing with occlusive dressings: a clinical focus. Dermatol Surg 2001: 27: 175-181.
15. Hutchinson II. Prevalence of wound infection under occlusive dressings: a collected survey of reported research. Wounds 1989: 1: 123-133.
16. Laurence JE. Dressings and wound infection. Am J Surg 1994: 167: 215-245.
17. Hutchinson II, Lawrence JE. Wound infection under occlusive dressings. J Hosp Infect 1991: 17: 83-94.
18. Lawrence JC. What material for dressings? Injury 1982: 13: 500-512.
19. Mertz PM, Marshal DA, Eaglstein WH. Occlusive wound dressings to prevent bacterial invasion and wound infection. J Am Acad Dermatol 1985: 12: 662-668.
20. Geronemus RG, Robins P. The effect of two new dressings on epidermal wound healing. J Dermatol Surg Oncol 1982: 8: 850-852.
21. Woodley DT, Chen JD, Kim JP et al. Re-epithelialization; human keratinocyte locomotion. Dermatol Clin 1993: 11: 641-646.
22. Nemeth AI, Eaglstein WH. Wound dressings and local treatment in leg ulcers: diagnosis and treatment. In: Westerhof W, ed. Leg ulcers: diagnosis and treatment. Amsterdam: Elsevier Science Publishers, 1993: 325-333.
23. Eaglstein WH, Falanga V. Chronic wounds. Surg Clin North Am 1997: 77: 689-700.
24. Sinclair RD, Ryan TJ. Types of chronic wounds: indications for enzymatic debridement. In: Westerhof W, Vanscheidt W, eds. Proteolytic enzymes and wound healing. New York: Springer-Verlag, 1994: 7-20.
25. Krane SM. Collagenases and collagen degradation. J Invest Dermatol 1982: 79: 83-86.
26. Stone LL. Bacterial debridement of the burn eschar: the in vivo activity of selected organisms. J Surg Res 1980: 29: 83-92.
27. Mortimer PS, Cherry GW, Jones RL, et al. The importance of elastic fibers in skin lymphatics. Br J Dermatol 1983: 108: 561-566.
28. Eaglstein WH, Falanga V. Chronic wounds. Surg Clin North Am 1997: 77: 689-700.
29. Westerhof W. Future prospects of proteolytic enzymes and wound healing. In: Westerhof W, Vanscheidt W, eds. Proteolytic enzymes and wound healing. New York: Springer-Verlag, 1994: 99-102.
30. Alteres WV. Debriding enzymes. J Enterostam Ther 1984: 11: 122-123.
31. Van Scheid TW, Weiss JM. Types of enzymes on the market. In: Westerhof W, Vanscheidt W, eds. Proteolytic enzymes and wound healing. New York: Springer-Verlag, 1994: 59-72.
32. Pullen R, Popp R, Volkers P, et al. Prospective randomized double-blind study of the wound - debriding effects of collagenase and fibrinolysin/ deoxyribonuclease in pressure ulcers. Age Ageing 2002: 31: 126-130.
33. Konig M, Vanscheidt W, Augustin M, Kapp H. Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomised trial. J Wound Care 2005: 14: 320-323.
34. Westerhof W, Jansen FC, DeWit FS. Controlled, double blind trial of fibrinolysin-desoxyribonuclease (Elase) solution in patients with chronic leg ulcers who are treated before autologous skin grafting. J Am Acad Dermatol 1987: 17: 32-38.
35. Falabella AF, Carson P, Eaglstein WH, Falanga V. The safety and efficacy of Elase in the treatment of chronic ulcers of the lower extremity. J Am Acad Dermatol 1998: 39: 737-740.
36. Shapira E, Giladi A, Neiman Z. Use of water-insoluble papain for debridement of burn eschar and necrotic tissue. Plast Reconstruct Surg 1973: 52: 279-281.
37. Alvarez OM, Fernandez-Obregon A, Roisin D, et al. A prospective, randomized, comparative study of collagenase and papain-urea for pressure ulcer debridement. Wounds 2002: 14: 293-301.
38. Apelqvist J, Ragnarson TG. Cavity foot ulcers in diabetic patients: a comparative study of cadexomer iodine ointment and standard treatment. An economic analysis alongside a clinical trial. Acta Derm Venereol 1996: 76: 231-235.
39. Martin SJ, Corrado OJ, Kay EA. Enzymatic debridement for necrotic wounds. J Wound Care 1996: 5: 310-311.
40. Maas-Irslinger R, Hensby CN, Farley KL. Experimental methods to demonstrate the efficacy and safety of Xenaderm™ ointment: a novel formulation for treatment of injured skin due to pressure ulcers. Wounds 2003: 15 (3 Suppl.): 2S-8S.
41. Kennedy KL, Tritch DL. Debridement. In: Krasner D, Kane D, eds. Chronic wound care, 2nd edn. Wayne, PA: Health Management Publications, 1997: 227-234.
42. Bergstrom N, Bennett MA, Carlson CE, et al. Treatment of Pressure Ulcers. Clinical Practice Guideline, No. 15. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 95-0652, December 1994.
43. Hulten L. Dressings for surgical wounds. Am J Surg 1994: 167: 521-524.
44. Granick MS, Jacoby M, Noruthrun S, et al. Clinical and economic impact of hydrosurgical debridement on chronic wounds. Wounds 2006: 18: 35-39.
45. Hell RC, Morton P, Brogden RN, et al. Dextranomer: a review of its general properties and therapeutic efficacy. Drugs 1979: 18: 89-102.
46. Weber DC, Parish LC, Witowski JA. Dextranomer in chronic wound healing. Clin Dermatol 1984: 2: 116-120.
47. Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg 1997: 38: 553-562.
48. Phelps JR, Fagan R, Pirela-Cruz MA. A case study of negative pressure wound therapy to manage acute necrotizing fasciitis. Ostomy Wound Manage 2006: 52: 54-59.
49. McCallon SK, Knight CA, Valiulus JP, et al. Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Manage 2000: 46: 28-34.
50. Falanga V. Iodine-containing pharmaceuticals: a reappraisal. In: Proceedings of the 6th European Conference on Advances in Wound Management, October 1-4, 1996, Amsterdam. MacMillan 1997: 191-194.
51. Viljanto J. Disinfection of surgical wounds without inhibition of normal wound healing. Arch Surg 1980: 115: 253-256.
52. Gruber RP, Vistnes L, Pardue R. The effect of commonly used antiseptics on wound healing. Plast Reconstr Surg 1975: 55: 472-476.
53. Sundberg J, Meller R. A retrospective review of the use of cadexomer iodine in the treatment of chronic wounds. Wounds 1997: 9: 68-86.
54. Mertz PM, Davis SC, Brewer L, et al. Can antimicrobials be effective without impairing wound healing? The evaluation of a cadexomer iodine ointment. Wounds 1994: 6: 184-193.
55. Oliveira-Gandia MF, Davis SC, Meitz PM. The evaluation of a cadexomer iodine dressing (lodoflex) in preventing the multiplication of methicillin-resistant Staphylococcus aureus. J Invest Dermatol 1995: 104: 654.